Subjects had been discouraged from adding additional drugs that are used for non-alcoholic steatohepatitis to their regimen. All subjects were given a standardized group of pragmatic recommendations about lifestyle changes and diet. A liver biopsy was performed 96 weeks after randomization, after which the analysis drugs were discontinued. Subjects were followed for an additional 24 weeks then. Secondary and Primary Outcomes The primary outcome was an improvement in histologic findings, which required a noticable difference by 1 or more points in the hepatocellular ballooning score; no increase in the fibrosis rating; and either a decrease in the experience score for non-alcoholic fatty liver disease to a score of 3 or less or a reduction in the activity score of at least 2 points, with at least a 1-point decrease in possibly the lobular steatosis or inflammation score.We are extremely pleased to begin this romantic relationship with among the premier Healthcare Networks in the united states, said Jeff Timbrook, CEO of Acuo Technologies. We are looking forward to building on this romantic relationship through ongoing collaboration with Allina’s thought leaders. By leveraging the data and shared eyesight of the Allina team, we will expand our commitment to continuous improvement to the market leading image management, archiving, and data migration features that are extensible and collaborative.